JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

JNJ

230.63

+2.12%↑

ABT

92.43

+0.79%↑

MDT

83.72

+0.54%↑

A

114.27

-5.32%↓

VEEV

156.08

-4.6%↓

Search

Treace Medical Concepts Inc

Cerrado

1.81 -1.09

Resumen

Variación precio

24h

Actual

Mínimo

1.73

Máximo

1.9

Métricas clave

By Trading Economics

Ingresos

6.9M

-9.4M

Ventas

12M

63M

Margen de beneficios

-15.026

Empleados

450

EBITDA

7M

-5.2M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+118.18% upside

Dividendos

By Dow Jones

Próximas Ganancias

7 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-448K

128M

Apertura anterior

2.9

Cierre anterior

1.81

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 abr 2026, 00:00 UTC

Ganancias

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 abr 2026, 00:00 UTC

Ganancias

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 abr 2026, 23:47 UTC

Charlas de Mercado

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

23 abr 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 abr 2026, 23:13 UTC

Adquisiciones, fusiones, absorciones

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 abr 2026, 22:33 UTC

Ganancias

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 abr 2026, 22:17 UTC

Ganancias

PLS Executed Offtake Agreement With Ronbay

23 abr 2026, 22:17 UTC

Ganancias

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 abr 2026, 22:16 UTC

Ganancias

PLS Commences Commissioning of Midstream Demonstration Plant

23 abr 2026, 22:15 UTC

Ganancias

PLS Group Reaffirms FY26 Guidance for All Metrics

23 abr 2026, 22:14 UTC

Ganancias

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 abr 2026, 22:14 UTC

Ganancias

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 abr 2026, 22:13 UTC

Ganancias

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 abr 2026, 22:12 UTC

Ganancias

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 abr 2026, 22:12 UTC

Ganancias

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 abr 2026, 22:11 UTC

Ganancias

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 abr 2026, 22:10 UTC

Ganancias

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 abr 2026, 22:09 UTC

Ganancias

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 abr 2026, 22:08 UTC

Ganancias

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 abr 2026, 22:04 UTC

Ganancias

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 abr 2026, 21:56 UTC

Charlas de Mercado
Ganancias

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 abr 2026, 21:48 UTC

Adquisiciones, fusiones, absorciones

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 abr 2026, 21:27 UTC

Ganancias

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 abr 2026, 21:25 UTC

Ganancias

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 abr 2026, 21:24 UTC

Ganancias

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 abr 2026, 21:24 UTC

Ganancias

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 abr 2026, 21:21 UTC

Ganancias

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 abr 2026, 21:21 UTC

Ganancias

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparación entre iguales

Cambio de precio

Treace Medical Concepts Inc previsión

Precio Objetivo

By TipRanks

118.18% repunte

Estimación a 12 Meses

Media 4.08 USD  118.18%

Máximo 7 USD

Mínimo 2.25 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Treace Medical Concepts Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

7.16 / 7.65Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat